Syngene International Ltd.
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022), is an innovation focused global discovery, development and manufacturing organization providing integrated scientific services to pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngene’s clientele include world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. Syngene’s innovative culture is driven by the passion of its 3500 strong team of scientists who work with clients from around the world to solve their scientific problems, improve R&D productivity, accelerate time to market and lower innovation costs. For more details, visit www.syngeneintl.com
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America|
|Affiliated categories:||API Contract Manufacturing |Biopharmaceuticals (general category) |Clinical Research (Field) More|
CPhI Worldwide 20195-7 November 2019 Frankfurt, Germany Visit us at stand 121C63 Book a meeting See our Exhibitor Profile See full Exhibitor List
CPhI & PMEC China 201918 - 20 June 2019 SNIEC, Shanghai, China We were at stand E8B17 See our Exhibitor Profile See full Exhibitor List
CPhI North America 201930 April - 2 May 2019 Chicago, USA We were at stand 2243 See our Exhibitor Profile See full Exhibitor List
Our Top products
Small & large molecule Discovery & Development
Discovery Chemistry, Discovery Biology, Integrated Drug DiscoveryMore info
Integrated Drug Substance-Drug Product development
Process R&D, Custom manufacturing, formulation development, Clinical supplies, safety assessmentMore info
News about Syngene International Ltd.
12 Sep 2018
Syngene International Expands Collaboration with Baxter
Syngene International Ltd., a leading global Contract Research Organization, announced the expansion of the scope of its R&D collaboration with Baxter Healthcare Corporation, a global healthcare company. As part of the expansion, Syngene will set up additional infrastructure at the dedicated Baxter Global Research Center (BGRC) as well as increase the size of its scientific team working on Baxter projects. The duration of the agreement has also been extended until 2024.Read more
9 Oct 2017
Syngene International Announces Broadening of Research Collaboration with Amgen Inc.
With the expansion, the floor space of Syngene Amgen Research & Development Center will double to 50,000 sq. ft. A team of up to 185 multi-disciplinary Syngene scientists will work in the areas of medicinal and process chemistry, biologics, bioprocess development, drug metabolism, pharmacokinetics, bioanalytical research and pharmaceutical development.Read more
Categories affiliated with Syngene International Ltd.
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation